Gut Microbiome vs Age: What a New Study Found

A new Danish study asked who looks more inflamed: older people, or people with a certain gut bacteria pattern? In 1,199 adults, the gut microbiome tracked inflammation and health measures more closely than age did.^[1] It’s an observational study, so it can’t say the microbiome causes any of this. Here’s what it found and what it doesn’t settle.

What the study did

Researchers drew on DanFunD, a population-based group of adults, and analyzed 1,199 people aged 20 to 72. Each person provided a stool sample, so the team could profile their gut microbiome. They also measured 30 inflammatory proteins in plasma and 19 biochemical and physiological measures. Then they asked how much of the person-to-person variation in those measures was explained by microbiome composition, compared with age.^[1]

What it found

Age was linked to about 40% of the inflammatory proteins and most of the physiological measures. But microbiome composition explained more of the variation than age did for 97% of the inflammatory proteins and 84% of the physiological measures.^[1]

The authors also grouped people into microbiome types, called enterotypes. People with the Bacteroides 2 enterotype had higher pro-inflammatory proteins and less favorable metabolic profiles, even in early adulthood. The authors describe an “inflammaging-like” pattern showing up as much as 37 years earlier than in people with other enterotypes. Bacteroides 2 was also linked to a higher risk of future disease across multiple organ systems (hazard ratio 1.21), and the inflammatory proteins accounted for part of that link in a statistical mediation analysis. A high-diversity enterotype went the other way: lower inflammation and lower disease risk.^[1]

What this study can’t tell you

• It’s association, not cause. The authors describe microbiome composition as a correlate of inflammation and disease trajectories, and as a “potentially modifiable determinant.” That last phrase is a hypothesis. This was an observational study; nobody changed anyone’s microbiome.^[1]
• It isn’t a fair race. Microbiome composition is a many-part profile; age is one number. A profile with that many parts has more ways to line up with a measurement, so “explains more variance than age” doesn’t mean the microbiome is the bigger driver.
• The hazard ratio is modest. 1.21 means about 21% higher relative risk of a new diagnosis for that enterotype in this group. That’s a population-level pattern, not a prediction for any one person. The abstract doesn’t give a confidence interval for it.
• It doesn’t say what shifts the pattern. The study tested no diet, supplement or lifestyle change, so it can’t tell you how to move from one enterotype to another, or whether doing so would change your risk.
• Enterotypes are groupings, not boxes. They’re a way to sort complicated data, and the abstract doesn’t claim they’re discrete biological categories.

What to do with it

There’s no test to order or product to buy off the back of this paper. It adds one large, population-based data point on the gut and inflammation, and it leaves the “what do I do about it” part open.

• Don’t buy a microbiome test to find out your “type.” This study grouped people statistically. It didn’t validate a consumer test as a way to predict your own risk.
• If inflammation or metabolic health is a concern, start with measurements you can act on. Ask your clinician whether a blood panel makes sense for you. We covered what’s worth asking about in three blood tests worth asking your clinician about for prevention.
• Check the design before you trust the headline. This study measured people once and looked at later diagnoses. It didn’t change anything. For a broader look at what the gut research does and doesn’t support, see the gut-brain axis: what’s real vs. overstated.

References

[1] Eriksen C, Chatzigiannidou I, Dehli RK, Johansen PL, Dantoft TM, Pedersen O, Hansen T, Linneberg A, Jess T, Allin KH, Jørgensen T, Kristiansen K, Brix S. Gut microbiota composition outperforms chronological age in predicting systemic inflammation and incident disease risk. Nat Commun, 2026;17(1):10606. DOI: https://doi.org/10.1038/s41467-026-77499-9. Finding as used (abstract): 1,199 adults aged 20-72 from the population-based DanFunD cohort; paired fecal microbiota profiles, 30 plasma cytokines and 19 biochemical and physiological measures; age was associated with 40% of cytokines and most physiological variables, but microbiota composition explained more variance than age for 97% of cytokines and 84% of physiological variables; Bacteroides 2 enterotype linked to elevated pro-inflammatory cytokines and adverse metabolic profiles, an inflammaging-like phenotype up to 37 years earlier than other enterotypes, and increased risk of future incident disease (hazard ratio 1.21) with inflammatory cytokines accounting for part of the association; a high-diversity enterotype was linked to lower inflammation and disease risk. Observational. ↑︎

Kurt Greiner

Kurt is a digital strategist and IT professional blending emerging technology with practical application, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.